[go: up one dir, main page]

DK3006038T3 - Enkeltdoser af oritavancin til behandling eller forebyggelse af en bakterieinfektion - Google Patents

Enkeltdoser af oritavancin til behandling eller forebyggelse af en bakterieinfektion Download PDF

Info

Publication number
DK3006038T3
DK3006038T3 DK15195726.3T DK15195726T DK3006038T3 DK 3006038 T3 DK3006038 T3 DK 3006038T3 DK 15195726 T DK15195726 T DK 15195726T DK 3006038 T3 DK3006038 T3 DK 3006038T3
Authority
DK
Denmark
Prior art keywords
oritavancin
prevention
treatment
bacterial infection
single doses
Prior art date
Application number
DK15195726.3T
Other languages
English (en)
Inventor
Dario Lehoux
Thomas Parr
Gregory Moeck
Pierre Etienne
Original Assignee
The Medicines Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41722337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3006038(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Medicines Co filed Critical The Medicines Co
Application granted granted Critical
Publication of DK3006038T3 publication Critical patent/DK3006038T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK15195726.3T 2008-08-30 2009-08-29 Enkeltdoser af oritavancin til behandling eller forebyggelse af en bakterieinfektion DK3006038T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9331408P 2008-08-30 2008-08-30
US9349708P 2008-09-02 2008-09-02
EP09810708.9A EP2337575B1 (en) 2008-08-30 2009-08-29 Methods of treatment using single doses of oritavancin

Publications (1)

Publication Number Publication Date
DK3006038T3 true DK3006038T3 (da) 2024-08-26

Family

ID=41722337

Family Applications (2)

Application Number Title Priority Date Filing Date
DK15195726.3T DK3006038T3 (da) 2008-08-30 2009-08-29 Enkeltdoser af oritavancin til behandling eller forebyggelse af en bakterieinfektion
DK09810708.9T DK2337575T3 (da) 2008-08-30 2009-08-29 Fremgangsmåde til behandling med enkeltdoser af oritavancin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK09810708.9T DK2337575T3 (da) 2008-08-30 2009-08-29 Fremgangsmåde til behandling med enkeltdoser af oritavancin

Country Status (18)

Country Link
US (2) US8420592B2 (da)
EP (3) EP3006038B1 (da)
JP (1) JP5782615B2 (da)
CN (2) CN106620649A (da)
AU (1) AU2009285564B2 (da)
CA (1) CA2736860C (da)
DK (2) DK3006038T3 (da)
EA (1) EA020490B1 (da)
ES (2) ES2570401T3 (da)
FI (1) FI3006038T3 (da)
HU (3) HUE068423T2 (da)
MX (1) MX2011002249A (da)
NL (1) NL300834I2 (da)
NO (1) NO2016019I2 (da)
NZ (1) NZ591525A (da)
PL (2) PL3006038T3 (da)
PT (1) PT3006038T (da)
WO (1) WO2010025438A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3006038T3 (fi) * 2008-08-30 2024-08-12 The Medicines Co Oritavansiinin yksittäisannokset bakteeri-infektion hoitoon tai ehkäisyyn
WO2010129233A2 (en) 2009-04-28 2010-11-11 Targanta Therapeutics Corp. Methods of treating bacterial infections using oritavancin
WO2014031681A1 (en) * 2012-08-20 2014-02-27 The University Of Chicago Inhibiting gram positive bacteria
WO2014176068A2 (en) * 2013-04-22 2014-10-30 The Medicines Company Treatment and prevention of bacterial skin infections using oritavancin
ES2949169T3 (es) * 2013-08-26 2023-09-26 Melinta Therapeutics Inc Procedimientos para tratar la bacteriemia y la osteomielitis utilizando oritavancina
EP3038615A4 (en) * 2013-08-28 2017-04-12 The Medicines Company Methods for treating bacterial infections using oritavancin and polymyxins
US20170119793A1 (en) * 2014-06-12 2017-05-04 Cem-102 Pharmaceuticals, Inc. Compositions and methods for treating bone and joint infections
EP3169345B1 (en) * 2014-07-17 2025-01-29 Melinta Therapeutics, LLC High purity oritavancin and method of producing same
WO2017143169A1 (en) * 2016-02-18 2017-08-24 The Medicines Company Oritavancin formulations
WO2017179003A1 (en) 2016-04-15 2017-10-19 Lupin Limited Topical compositions for ophthalmic and otic use
CN108409837B (zh) * 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5994297A (en) * 1997-08-22 1999-11-30 Eli Lilly And Company Therapy for Staphylococcus aureus
UA73937C2 (en) * 1999-05-03 2005-10-17 Lilly Co Eli Method of treatment for long-term prevention of s. pneumoniae in susceptible individuals and pharmaceutical composition for realizing this method
US6858584B2 (en) 2000-05-02 2005-02-22 Theravance, Inc. Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
US20030176327A1 (en) * 2001-10-25 2003-09-18 Cassell Gail Houston Antibiotics for treating biohazardous bacterial agents
CA2487094A1 (en) * 2002-05-28 2003-12-11 Becton, Dickinson And Company Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
US20040147441A1 (en) * 2002-08-23 2004-07-29 Leach Timothy S. Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
EP2068890B1 (en) * 2006-09-25 2014-01-08 The Medicines Company Use of oritavancin for prevention and treatment of anthrax
FI3006038T3 (fi) * 2008-08-30 2024-08-12 The Medicines Co Oritavansiinin yksittäisannokset bakteeri-infektion hoitoon tai ehkäisyyn
WO2010129233A2 (en) * 2009-04-28 2010-11-11 Targanta Therapeutics Corp. Methods of treating bacterial infections using oritavancin
EP3038615A4 (en) * 2013-08-28 2017-04-12 The Medicines Company Methods for treating bacterial infections using oritavancin and polymyxins

Also Published As

Publication number Publication date
NZ591525A (en) 2014-03-28
EP3006038A1 (en) 2016-04-13
US20110201546A1 (en) 2011-08-18
NL300834I2 (da) 2016-11-16
CA2736860A1 (en) 2010-03-04
PT3006038T (pt) 2024-08-23
HUE027373T2 (hu) 2016-09-28
NO2016019I2 (no) 2019-01-25
EP4464375A3 (en) 2025-02-26
CA2736860C (en) 2020-04-28
DK2337575T3 (da) 2016-05-23
CN106620649A (zh) 2017-05-10
ES2994966T3 (en) 2025-02-04
CN102215858A (zh) 2011-10-12
FI3006038T3 (fi) 2024-08-12
PL3006038T3 (pl) 2024-11-12
US8420592B2 (en) 2013-04-16
EA201100413A1 (ru) 2012-01-30
NO2016019I1 (no) 2016-10-11
HUS1600039I1 (hu) 2016-11-28
MX2011002249A (es) 2011-06-24
PL2337575T3 (pl) 2016-09-30
HUE068423T2 (hu) 2024-12-28
JP2012501349A (ja) 2012-01-19
EP3006038B1 (en) 2024-07-03
US20130172237A1 (en) 2013-07-04
WO2010025438A2 (en) 2010-03-04
AU2009285564A1 (en) 2010-03-04
EP2337575A4 (en) 2012-10-17
ES2570401T3 (es) 2016-05-18
EP2337575B1 (en) 2016-04-13
EP2337575A1 (en) 2011-06-29
EA020490B1 (ru) 2014-11-28
AU2009285564B2 (en) 2014-05-22
JP5782615B2 (ja) 2015-09-24
EP4464375A2 (en) 2024-11-20
WO2010025438A9 (en) 2010-05-14

Similar Documents

Publication Publication Date Title
DK3006038T3 (da) Enkeltdoser af oritavancin til behandling eller forebyggelse af en bakterieinfektion
AP2010005480A0 (en) Small molecule inhibitors for the treatment or prevention of denque virus infection.
DK3251678T3 (da) Benzoxaborolderivater til behandling af bakterieinfektioner
DK2154971T3 (da) Synergistisk farmaceutisk kombination til behandling af cancer
DK3494972T3 (da) Kombinationer af dolutegravir og lamivudin til behandling af HIV-infektion
DK2502172T3 (da) Hypoglykæmiske behandlingssystemer
DK2146732T3 (da) Fremgangsmåder til behandling eller forebyggelse af emese ved hjælp af væksthormonsekretagoger
DK2207775T3 (da) 4-Benzylamino-1-carboxyacylpiperidinderivater som CETP-inhibitorer, som er anvendelige til behandling af sygdomme som hyperlipidæmi eller arteriosclerose
FI20085275A0 (fi) Menetelmä biomassan käsittelemiseksi
DK2349310T3 (da) Polypeptid til behandling eller forebyggelse af adhæsioner
IL202450A (en) Pharmaceutical composition to treat influenza virus infection
BRPI0823131A2 (pt) Bandejas curúrgicas estéreis
BR112013015771A2 (pt) derivados de ciclosporina para o tratamento e a prevenção de uma infecção viral
DK2209784T3 (da) Forbindelser til behandling af hepatitis C
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2296651T3 (da) 5-hydroxymethyl-oxazolidin-2-on-derivater til behandling af bakterielle intestinale sygdomme
DK2421539T3 (da) Fremgangsmåder til at behandle en bakteriel lungeinfektion ved at anvende fluorquinoloner
DK3441054T3 (da) Indretning til behandling af vaginal svampeinfektion
DK2109449T3 (da) Lægemiddel til behandling af endometriose
DK2323686T3 (da) Adiponectin til behandling af lungesygdom
DK2310017T3 (da) Nifurtimox til behandling af sygdomme fremkaldt af trichomonadida
DK2361627T3 (da) Sammensætning til forebyggelse eller behandling af øjensygdomme
IL193466A0 (en) Drugs for treating infections with influenza viruses
BRPI0818844A2 (pt) Métodos de inibição de infecção viral.
DK2293810T3 (da) Muteret tat-oyi-protein til forebyggelse eller behandling af aids